200 related articles for article (PubMed ID: 555683)
21. Assay for thrombopoietin: a comparison of time of isotope incorporation into platelets and the effects of different strains and sexes of mice.
McDonald TP; Clift R; Cottrell M
Exp Hematol; 1979 Jul; 7(6):289-96. PubMed ID: 488187
[TBL] [Abstract][Full Text] [Related]
22. Idiopathic thrombocytopenic purpura and dysmegakaryocytopoiesis.
Wang L; Li Y; Hou M
Crit Rev Oncol Hematol; 2007 Nov; 64(2):83-9. PubMed ID: 17900920
[TBL] [Abstract][Full Text] [Related]
23. Reticulated platelets as a marker of megakaryopoiesis in liver cirrhosis; relation to thrombopoietin and hepatocyte growth factor serum concentration.
Panasiuk A; Prokopowicz D; Zak J; Panasiuk B
Hepatogastroenterology; 2004; 51(58):1124-8. PubMed ID: 15239259
[TBL] [Abstract][Full Text] [Related]
24. Thrombopoiesis: new concepts.
van Geet C
Verh K Acad Geneeskd Belg; 2004; 66(1):5-24; discussion 24-7. PubMed ID: 15074080
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of hNUDC as a novel accumulator that specifically acts on in vitro megakaryocytopoiesis and in vivo platelet production.
Wei MX; Yang Y; Ge YC; Xu P
J Cell Biochem; 2006 May; 98(2):429-39. PubMed ID: 16440315
[TBL] [Abstract][Full Text] [Related]
26. The (patho)physiology of megakaryocytopoiesis: from thrombopoietin in diagnostics and therapy to ex vivo generated cellular products.
Tijssen MR; van der Schoot CE; Voermans C; Zwaginga JJ
Vox Sang; 2004 Jul; 87 Suppl 2():52-5. PubMed ID: 15209879
[No Abstract] [Full Text] [Related]
27. [Thrombopoietin and the control of platelet production (author's transl)].
Dassin E
Nouv Rev Fr Hematol (1978); 1979; 21(2):209-18. PubMed ID: 390495
[TBL] [Abstract][Full Text] [Related]
28. Thrombopoietin: its biology, purification, and characterization.
McDonald TP
Exp Hematol; 1988 Mar; 16(3):201-5. PubMed ID: 3276546
[TBL] [Abstract][Full Text] [Related]
29. Biologic aspects of thrombopoietins and the development of therapeutic agents.
Solberg LA
Curr Hematol Rep; 2005 Nov; 4(6):423-8. PubMed ID: 16232377
[TBL] [Abstract][Full Text] [Related]
30. Sustained thrombocytopenia in mice: serial studies of megakaryocytes and platelets.
Stenberg PE; Levin J; Corash L
Exp Hematol; 1990 Feb; 18(2):124-32. PubMed ID: 2303104
[TBL] [Abstract][Full Text] [Related]
31. Partial purification and biological properties of thrombopoietin extracted from the urine of aplastic anemia patients.
Miyake T; Kawakita M; Enomoto K; Murphy MJ
Stem Cells (1981); 1982; 2(3):129-44. PubMed ID: 7163915
[TBL] [Abstract][Full Text] [Related]
32. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
33. Effects of antiplatelet serum and thrombopoietin on the percentage of small acetylcholinesterase-positive cells in bone marrow of mice.
Kalmaz GD; McDonald TP
Exp Hematol; 1981 Nov; 9(10):1002-10. PubMed ID: 7308323
[TBL] [Abstract][Full Text] [Related]
34. Biological characteristics of megakaryocytes: specific lineage commitment and associated disorders.
Sun L; Hwang WY; Aw SE
Int J Biochem Cell Biol; 2006; 38(11):1821-6. PubMed ID: 16730215
[TBL] [Abstract][Full Text] [Related]
35. Ultrastructural analysis of acute immune thrombocytopenia in mice: dissociation between alterations in megakaryocytes and platelets.
Stenberg PE; Levin J
J Cell Physiol; 1989 Oct; 141(1):160-9. PubMed ID: 2777899
[TBL] [Abstract][Full Text] [Related]
36. Regeneration of megakaryocytopoiesis and thrombopoiesis in vitro from X-irradiated human hematopoietic stem cells.
Kashiwakura I; Inanami O; Abe Y; Satoh K; Takahashi TA; Kuwabara M
Radiat Res; 2006 Aug; 166(2):345-51. PubMed ID: 16881735
[TBL] [Abstract][Full Text] [Related]
37. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
[TBL] [Abstract][Full Text] [Related]
38. [Effect of thrombopenia on bone marrow CFU-S level and its capability to modify the circulating thrombocyte number].
Zöllei M; Arokszállásy E; Krizsa F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):483-7. PubMed ID: 6182068
[TBL] [Abstract][Full Text] [Related]
39. Determination of thrombopoietin-derived peptides recognized by both cellular and humoral immunities in healthy donors and patients with thrombocytopenia.
Takedatsu H; Yoshimoto K; Okamura T; Miyazaki H; Kuwaki T; Sata M; Itoh K
Stem Cells; 2005 Aug; 23(7):975-82. PubMed ID: 16043461
[TBL] [Abstract][Full Text] [Related]
40. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
